Infinity Pharmaceuticals Inc
NASDAQ:INFI
Infinity Pharmaceuticals Inc
Total Assets
Infinity Pharmaceuticals Inc
Total Assets Peer Comparison
Competitive Total Assets Analysis
Latest Figures & CAGR of Competitors
Company | Total Assets | CAGR 3Y | CAGR 5Y | CAGR 10Y | |
---|---|---|---|---|---|
Infinity Pharmaceuticals Inc
NASDAQ:INFI
|
Total Assets
$21.2m
|
CAGR 3-Years
-24%
|
CAGR 5-Years
-16%
|
CAGR 10-Years
-23%
|
|
Abbvie Inc
NYSE:ABBV
|
Total Assets
$148.9B
|
CAGR 3-Years
0%
|
CAGR 5-Years
21%
|
CAGR 10-Years
18%
|
|
Gilead Sciences Inc
NASDAQ:GILD
|
Total Assets
$56.3B
|
CAGR 3-Years
-6%
|
CAGR 5-Years
-2%
|
CAGR 10-Years
7%
|
|
Amgen Inc
NASDAQ:AMGN
|
Total Assets
$93B
|
CAGR 3-Years
14%
|
CAGR 5-Years
8%
|
CAGR 10-Years
3%
|
|
Vertex Pharmaceuticals Inc
NASDAQ:VRTX
|
Total Assets
$23.9B
|
CAGR 3-Years
25%
|
CAGR 5-Years
30%
|
CAGR 10-Years
27%
|
|
Regeneron Pharmaceuticals Inc
NASDAQ:REGN
|
Total Assets
$34.4B
|
CAGR 3-Years
25%
|
CAGR 5-Years
22%
|
CAGR 10-Years
27%
|
See Also
What is Infinity Pharmaceuticals Inc's Total Assets?
Total Assets
21.2m
USD
Based on the financial report for Jun 30, 2023, Infinity Pharmaceuticals Inc's Total Assets amounts to 21.2m USD.
What is Infinity Pharmaceuticals Inc's Total Assets growth rate?
Total Assets CAGR 10Y
-23%
Over the last year, the Total Assets growth was -66%. The average annual Total Assets growth rates for Infinity Pharmaceuticals Inc have been -24% over the past three years , -16% over the past five years , and -23% over the past ten years .